Abstract
The Rho activator ECT2 functions as a key regulator in cytokinesis. ECT2 is phosphorylated during G2/M phase, but the physiological significance of this event is not well known. In this study, we show that phosphorylation of ECT2 at threonine-341 (T341) affects the autoregulatory mechanism of ECT2. In G2/M phase, ECT2 was phosphorylated at T341 most likely by Cyclin B/Cyclin-dependent kinase 1 (Cdk1), and then dephosphorylated before cytokinesis. Depletion of ECT2 by RNA interference (RNAi) efficiently induced multinucleate cells. Expression of the phospho-deficient mutant of ECT2 at T341 suppressed the multinucleation induced by RNAi to ECT2, indicating that ECT2 is biologically active even when it is not phosphorylated at T341. However, the phospho-mimic mutation at T341 weakly stimulates the catalytic activity of ECT2 as detected by serum response element reporter gene assays. As T341 is located at the hinge region of the N-terminal regulatory domain and C-terminal catalytic domain, phosphorylation of T341 may help accessing downstream signaling molecules to further activate ECT2. We found that the phospho-mimic mutation T341D increases binding with itself or the N-terminal half of ECT2. These results suggest a conformational change of ECT2 upon phosphorylation at T341. Therefore, ECT2 activity might be regulated by the phosphorylation status of T341. We propose that T341 phosphorylation by Cyclin B/Cdk1 could be a trigger for further activation of ECT2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Echard A, O'Farrell PH . (2003). Curr Biol 13: 373–383.
Elia AE, Cantley LC, Yaffe MB . (2003). Science 299: 1228–1231.
Hill CS, Wynne J, Treisman R . (1995). Cell 81: 1159–1170.
Hirose K, Kawashima T, Iwamoto I, Nosaka T, Kitamura T . (2001). J Biol Chem 276: 5821–5828.
James P, Halladay J, Craig EA . (1996). Genetics 144: 1425–1436.
Kim JE, Billadeau DD, Chen J . (2005). J Biol Chem 280: 5733–5739.
Kimura K, Tsuji T, Takada Y, Miki T, Narumiya S . (2000). J Biol Chem 275: 17233–17236.
Lee KS, Erikson RL . (1997). Mol Cell Biol 17: 3408–3417.
Liu XF, Ishida H, Raziuddin R, Miki T . (2004). Mol Cell Biol 24: 6665–6675.
Lorenzi MV, Castagnino P, Chen Q, Hori Y, Miki T . (1999). Oncogene 18: 4742–4755.
Lowery DW, Mohammad DH, Elia AE, Yaffe MB . (2004). Cell Cycle 3: 128–131.
Matuliene J, Kuriyama R . (2004). Mol Biol Cell 15: 3083–3094.
Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N et al. (1997). Eur J Biochem 243: 527–536.
Miki T, Smith C, Long J, Eva A, Fleming T . (1993). Nature 362: 462–465.
Mishima M, Pavicic V, Gruneberg U, Nigg EA, Glotzer M . (2004). Nature 430: 908–913.
O'Keefe L, Somers WG, Harley A, Saint R . (2001). Cell Struct Funct 26: 619–626.
Obaya AJ, Sedivy JM . (2002). Cell Mol Life Sci 59: 126–142.
Saito S, Liu XF, Kamijo K, Raziuddin R, Tatsumoto T, Okamoto I et al. (2004). J Biol Chem 279: 7169–7179.
Saito S, Tatsumoto T, Lorenzi MV, Chedid M, Kapoor V, Sakata H et al. (2003). J Cell Biochem 90: 819–836.
Sakata H, Rubin JS, Taylor WG, Miki T . (2000). Hepatology 32: 193–199.
Shah OJ, Ghosh S, Hunter T . (2003). J Biol Chem 278: 16433–16442.
Tatsumoto T, Xie X, Blumenthal R, Okamoto I, Miki T . (1999). J Cell Biol 147: 921–927.
Thiel DA, Reeder MK, Pfaff A, Coleman TR, Sells MA, Chernoff J . (2002). Curr Biol 12: 1227–1232.
Ubersax JA, Woodbury EL, Quang PN, Paraz M, Blethrow JD, Shah K et al. (2003). Nature 425: 859–864.
Wheatley SP, Hinchcliffe EH, Glotzer M, Hyman AA, Sluder G, Wang Y . (1997). J Cell Biol 138: 385–393.
Yoshizaki H, Ohba Y, Parrini MC, Dulyaninova NG, Bresnick AR, Mochizuki N et al. (2004). J Biol Chem 279: 44756–44762.
Acknowledgements
This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute Center for Cancer Research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hara, T., Abe, M., Inoue, H. et al. Cytokinesis regulator ECT2 changes its conformation through phosphorylation at Thr-341 in G2/M phase. Oncogene 25, 566–578 (2006). https://doi.org/10.1038/sj.onc.1209078
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209078
Keywords
This article is cited by
-
Inference on autoregulation in gene expression with variance-to-mean ratio
Journal of Mathematical Biology (2023)
-
Cytoplasmic expression of epithelial cell transforming sequence 2 in lung adenocarcinoma and its implications for malignant progression
Laboratory Investigation (2019)
-
Modulation of alternative splicing induced by paclitaxel in human lung cancer
Cell Death & Disease (2018)
-
Plk1 regulates contraction of postmitotic smooth muscle cells and is required for vascular homeostasis
Nature Medicine (2017)
-
Ect2 links the PKCι–Par6α complex to Rac1 activation and cellular transformation
Oncogene (2009)